NC TraCS Institute-CTRC; University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
Hospital in Chapel Hill, North Carolina
Burnett-Womack Building, 160, Dental Cir, Chapel Hill, NC 27514
About NC TraCS Institute-CTRC; University of North Carolina at Chapel Hill
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Gilead Sciences
8
University of North Carolina, Chapel Hill
7
Aimmune Therapeutics, Inc.
5
Pfizer
5
Vertex Pharmaceuticals Incorporated
4
GE Healthcare
1
Neuraly, Inc.
1
Xencor, Inc.
1
Clinical Trials at NC TraCS Institute-CTRC; University of North Carolina at Chapel Hill
During the past decade, NC TraCS Institute-CTRC; University of North Carolina at Chapel Hill conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 13 clinical trials were completed, i.e. on
average, 52% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 8 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study to Evaluate the Safety and Efficacy of Stribild Versus Atripla in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults
2010-03-01
2014-09-01
Completed
707
Study to Evaluate the Safety and Efficacy of a Single Tablet Regimen of Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate Compared With a Single Tablet Regimen of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
2011-02-01
2014-02-01
Completed
799
Do Furanocoumarins Mediate the Fexofenadine-grapefruit Juice Interaction?
2009-09-01
2011-04-01
Completed
18
Altered Drug Disposition and Biomarkers for Diagnosis of Chronic Inflammatory Liver Disease
2012-11-01
2014-06-01
Completed
22
A Feasibility Study to Assess Tenofovir and Maraviroc Protection Against HIV-1 in Cervical and Vaginal Explants
2014-02-01
2014-04-01
Completed
6
Comparison of Virologic and Immunologic Responses to Raltegravir and Dolutegravir in the Gastrointestinal Tract of HIV-Positive Adults
2014-10-01
2015-10-01
Completed
20
Peanut Allergy Oral Immunotherapy Study of AR101 for Desensitization in Children and Adults (PALISADE)
2015-12-22
2018-07-02
Completed
555
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "NC TraCS Institute-CTRC; University of North Carolina at Chapel Hill" #1 sponsor was "Gilead Sciences" with 8 trials, followed by "University of North Carolina, Chapel Hill" with 7 trials
sponsored, "Aimmune Therapeutics, Inc." with 5 trials sponsored, "Pfizer" with 5 trials sponsored and "Vertex Pharmaceuticals Incorporated"
with 5 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "NC TraCS Institute-CTRC; University of North Carolina at Chapel Hill"
#1 collaborator was "ICON plc" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator, "PPD" with 1 trials as a collaborator and "Syneos Health" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 7 trials.
Clinical Trials Conditions at NC TraCS Institute-CTRC; University of North Carolina at Chapel Hill
According to Clinical.Site data, the most researched conditions in "NC TraCS Institute-CTRC; University of North Carolina at Chapel Hill" are
"Peanut Allergy" (5 trials), "Cystic Fibrosis" (3 trials), "HIV-1 Infection" (3 trials), "Alopecia Areata" (2 trials) and "Nonalcoholic Steatohepatitis" (2 trials). Many other conditions were trialed in "NC TraCS Institute-CTRC; University of North Carolina at Chapel Hill" in a lesser frequency.
Clinical Trials Intervention Types at NC TraCS Institute-CTRC; University of North Carolina at Chapel Hill
Most popular intervention types in "NC TraCS Institute-CTRC; University of North Carolina at Chapel Hill" are "Drug" (25 trials), "Biological" (8 trials), "Procedure" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "AR101" (4 trials), "B/F/TAF" (2 trials), "ELX/TEZ/IVA" (2 trials) and "IVA" (2 trials). Other intervention names were less common.
Clinical Trials Genders at NC TraCS Institute-CTRC; University of North Carolina at Chapel Hill
The vast majority of trials in "NC TraCS Institute-CTRC; University of North Carolina at Chapel Hill" are
31 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at NC TraCS Institute-CTRC; University of North Carolina at Chapel Hill
Currently, there are NaN active trials in "NC TraCS Institute-CTRC; University of North Carolina at Chapel Hill".
undefined are not yet recruiting,
2 are recruiting,
4 are Active, not recruiting,
and 2 are Enrolling by invitation.
In total, there were 19 completed trials in NC TraCS Institute-CTRC; University of North Carolina at Chapel Hill,
1 suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in NC TraCS Institute-CTRC; University of North Carolina at Chapel Hill, 4 "Phase 1"
clinical trials were conducted, 7 "Phase 2" clinical
trials and 19 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 1 trials that are defined as “Not Applicable".